Q32 Bio Inc. SEC filings QTTB
Q32 Bio Inc. has 588 filings in SEC EDGAR's recent list, going back to Jan 6, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 15, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 27, 2026 | May 26, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Other events
|
Apr 24, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Dec 1, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 25, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 19, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2025 | Apr 25, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 8, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 27, 2024 | Mar 25, 2024 |
| 8-K/A |
Amended current report
Other events
|
Mar 22, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 15, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 26, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 3, 2024 | Dec 29, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Jul 27, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Other events
|
Jun 13, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2022 | Apr 19, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Mar 16, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 18, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Feb 3, 2022 | Jan 28, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2021 | Apr 7, 2021 |
| 8-K |
Current report
Other events
|
Apr 9, 2021 | Apr 6, 2021 |
| 8-K |
Current report
Agreement ended
|
Mar 1, 2021 | Feb 26, 2021 |
| 8-K |
Current report
Other events
|
Feb 8, 2021 | Feb 8, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 18, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2020 | Jul 21, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 10, 2020 |
| 8-K |
Current report
Other events
|
Dec 19, 2019 | Dec 17, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 15, 2019 | Jul 9, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 27, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2019 | Jun 6, 2019 |
| 8-K |
Current report
Other events
|
Apr 11, 2019 | Apr 9, 2019 |
| 8-K |
Current report
Results of operations, Other events
|
Apr 8, 2019 | Apr 4, 2019 |
| 8-K |
Current report
Material agreement
|
Apr 1, 2019 | Apr 1, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 3, 2018 | Apr 2, 2018 |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QTTB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661998
- Former names
- Q32 Bio Inc. (until Nov 4, 2026); Homology Medicines, Inc. (until Mar 22, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.